In the search for novel effective compounds to use in thyroid cancer (TC) unresponsive to current treatment, attention has recently focused on plant-derived compounds with anticancer activity. In this review, we discuss the preclinical studies demonstrating phytochemical activity against thyroid cancer cells.
In particular, we describe their antiproliferative properties or ability to re-induce iodine retention, thus supporting their potential use as single agents or adjuvants in radioiodine-resistant thyroid cancer treatment.
This is a preview of subscription content, access via your institution.
Buy single article
Instant access to the full article PDF.
Tax calculation will be finalised during checkout.
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
Tax calculation will be finalised during checkout.
S. Bulotta, M. Celano, G. Costante, D. Russo, Novel therapeutic options for radioiodine refractory thyroid cancer: re-differentiation and beyond. Curr. Opin. Oncol. 32, 13–19 (2020)
C. Durante, N. Haddy, E. Baudin, S. Leboulleux, D. Hartl, J.P. Travagli, B. Caillou, M. Ricard, J.D. Lumbroso, F. De Vathaire, M. Schlumberger, Long-term outcome of 444 patients with distant metastases from papillary and follicular thyroid carcinoma: benefits and limits of radioiodine therapy. J. Clin. Endocrinol. Metab. 91, 2892–2899 (2006)
S. Wächter, A. Wunderlich, B.H. Greene, S. Roth, M. Elxnat, S.A. Fellinger, F.A. Verburg, M. Luster, D.K. Bartsh, P. Di Fazio, Selumetinib activity in thyroid cancer cells: modulation of sodium iodide symporter and associated miRNAs. Int. J. Mol. Sci. 19(7), 2077 (2018)
M.E. Cabanillas, M. Ryder, C. Jimenez, Targeted therapy for advanced thyroid cancer: kinase inhibitors and beyond. Endocr. Rev. 40(6), 1573–1604 (2019)
S. Bulotta, M. Celano, G. Costante, D. Russo, Emerging strategies for managing differentiated thyroid cancers refractory to radioiodine. Endocrine 52, 214–221 (2016)
G.E. Naoum, M. Morkos, B. Kim, W. Arafat, Novel targeted therapies and immunotherapy for advanced thyroid cancers. Mol. Cancer 17(1), 51 (2018)
A. Jayarangaiah, G. Sidhu, J. Brown, O. Barrett-Campbell, G. Bahtiyar, I. Youssef, S. Arora, S. Skwiersky, S. McFarlane, Therapeutic options for advanced thyroid cancer. Int. J. Clin. Endocrinol. Metab. 5(1), 26–34 (2019)
R. Kotecha, A. Takami, J.L. Espinoza, Dietary phytochemicals and cancer chemoprevention: a review of the clinical evidence. Oncotarget 7(32), 52517–52529 (2016)
A. Ranjan, S. Ramachandran, N. Gupta, I. Kaushik, S. Wright, S. Srivastava, H. Das, S. Srivastava, S. Prasad, S.K. Srivastava, Role of phytochemicals in cancer prevention. Int. J. Mol. Sci. 20(20), 4981 (2019)
H.J. Shin, K.A. Hwang, K.C. Choi, Antitumor effect of various phytochemicals on diverse types of thyroid cancers. Nutrients 11(1), 125 (2019)
F. Pistollato, M. Masias, P. Agudo, F. Giampieri, M. Battino, Effects of phytochemicals on thyroid function and their possible role in thyroid disease. Ann. N. Y. Acad. 1443(1), 3–19 (2019)
V. Neveu, J. Perez-Jimenez, F. Vos, V. Crespy, L. du Chaffaut, L. Mennen, C. Knox, R. Eisner, J. Cruz, D. Wishart, A. Scalbert, Phenol-explorer: an online comprehensive database on polyphenol contents in foods. Database 2010, bap024 (2010)
A. Rauf, M. Imran, M.S. Butt, M. Nadeem, D.G. Peters, M.S. Mubarak, Resveratrol as an anti-cancer agent: a review. Crit. Rev. Food Sci. Nutr. 58, 1428–1447 (2018)
X.M. Yu, R. Jaskula-Sztul, K. Ahmed, A.D. Harrison, M. Kunnimalaiyaan, H. Chen, Resveratrol induces differentiation markers expression in anaplastic thyroid carcinoma via activation of Notch1 signaling and suppresses cell growth. Mol. Cancer Ther. 12(7), 1276–1287 (2013)
Y.T. Li, X.T. Tian, M.L. Wu, X. Zheng, Q.Y. Kong, X.X. Cheng, G.W. Zhu, J. Liu, H. Li, Resveratrol suppresses the growth and enhances retinoic acid sensitivity of anaplastic thyroid cancer cells. Int. J. Mol. Sci. 19(4), 1030 (2018)
L. Allegri, F. Rosignolo, C. Mio, S. Filetti, F. Baldan, G. Damante, Effects of nutraceuticals on anaplastic thyroid cancer cells. J. Cancer Res. Clin. Oncol. 144, 285–294 (2018)
J. Wu, Y.T. Li, X.T. Tian, Y.S. Liu, M.L. Wu, P.N. Li, J. Liu, STAT3 signaling statuses determine the fate of resveratrol-treated anaplastic thyroid cancer cells. Cancer Biomark. 27, 461–469 (2020)
G. Xu, J. Chen, J. Wang, J. Xiao, N. Zhang, Y. Chen, H. Yu, G. Wang, Y. Zhao, Resveratrol inhibits the tumorigenesis of follicular thyroid cancer via ST6GAL2-regulated activation of the Hippo signaling pathway. Mol. Ther. Oncolytics 16, 124–133 (2020)
A. Giordano, G. Tommonaro, Curcumin and cancer. Nutrients 11(10), 2376 (2019)
L. Zhang, X. Cheng, Y. Gao, J. Bao, H. Guan, R. Lu, H. Yu, Q. Xu, Y. Sun, Induction of ROS-independent DNA damage by curcumin leads to G2/M cell cycle arrest and apoptosis in human papillary thyroid carcinoma BCPAP cells. Food Funct. 7, 315–325 (2016)
S. Schwertheim, F. Wein, K. Lennartz, K. Worm, K.W. Schmid, Curcumin induces G2/M arrest, apoptosis, NF-kB inhibition, and expression of differentiation genes in thyroid carcinoma cells. J. Cancer Res. Clin. Oncol. 143(7), 1143–1154 (2017)
A. Perna, A.D. Luca, A. Adelfi, L. Pasquale, B. Varriale, T. Esposito, Effects of different extracts of curcumin on TPC1 papillary thyroid cancer cell line. BMC Complement. Altern. Med. 18(1), 63 (2018)
T. Esposito, A. Lucariello, E. Hay, M. Contieri, P. Tammaro, B. Varriale, G. Guerra, A. De Luca, A. Perna, Effects of curcumin and its adjuvant on TPC1 thyroid cell line. Chem. Biol. Interact. 305, 112–118 (2019).
A.Q. Khan, E.I. Ahmed, N. Elareer, H. Fathima, K.S. Prabhu, K.S. Siveen, M. Kulinski, F. Azizi, S. Dermime, A. Ahmad, M. Steinhoff, S. Uddin, Curcumin-mediated apoptotic cell death in papillary thyroid cancer and cancer stem-like cells through targeting of the JAK/STAT3 signaling pathway. Int. J. Mol. Sci. 21(2), 438 (2020)
L. Zhang, X. Cheng, S. Xu, J. Bao, X. Yu, Curcumin induces endoplasmic reticulum stress-associated apoptosis in human papillary thyroid carcinoma BCPAP cells via disruption of intracellular calcium homeostasis. Medicine 97(24), e11095 (2018)
C.Y. Zhang, L. Zhang, H.X. Yu, J.D. Bao, Z. Sun, R.R. Lu, Curcumin inhibits invasion and metastasis in K1 papillary thyroid cancer cells. Food Chem. 139, 1021–1028 (2013)
C.Y. Zhang, L. Zhang, H.X. Yu, J.D. Bao, R.R. Lu, Curcumin inhibits the metastasis of k1 papillary thyroid cancer cells via modulating e-cadherin and matrix metalloproteinase-9 expression. Biotechnol. Lett. 35, 995–1000 (2013)
C. Tan, L. Zhang, X. Cheng, X.F. Lin, R.R. Lu, J.D. Bao, H.X. Yu, Curcumin inhibits hypoxia-induced migration in k1 papillary thyroid cancer cells. Exp. Biol. Med. 240, 925–935 (2015)
L. Zhang, X. Cheng, Y. Gao, C. Zhang, J.D. Bao, X. Guan, H. Yu, R. Lu, Q. Xu, Y. Sun, Curcumin inhibits metastasis in human papillary thyroid carcinoma BCPAP cells via down-regulation of the TGF-beta/Smad2/3 signaling pathway. Exp. Cell. Res. 341, 157–165 (2016)
X. Xu, J. Qin, W. Liu, Curcumin inhibits the invasion of thyroid cancer cells via down-regulation of pi3k/akt signaling pathway. Gene 546, 226–232 (2014)
M. Russo, G.L. Russo, M. Daglia, P.D. Kasi, S. Ravi, S.F. Nabavi, S.M. Nabavi, Understanding genistein in cancer: The “good” and the “bad” effects: a review. Food Chem. 196, 589–600 (2016)
V. Mukund, D. Mukund, V. Sharma, M. Mannarapu, A. Alam, Genistein: Its role in metabolic diseases and cancer. Crit. Rev. Oncol. Hematol. 119, 13–22 (2017)
S.M. Ferrari, A. Antonelli, P. Guidi, M. Bernardeschi, V. Scarcelli, P. Fallahi, G. Frenzilli, Genotoxicity evaluation of the soybean isoflavonegenistein in human papillary thyroid cancer cells. Study of its potential use in thyroid cancer therapy. Nutr. Cancer 71(8), 1335–1344 (2019)
C. Zhang, B. Lv, C. Yi, X. Cui, S. Sui, X. Li, M. Qi, C. Hao, B. Han, Z. Liu, Genistein inhibits human papillary thyroid cancer cell detachment, invasion and metastasis. J. Cancer 10(3), 737–748 (2019)
A.D. Khwairakpam, D. Bordoloi, K.K. Thakur, J. Monisha, F. Arfuso, G. Seth, S. Mishra, A.P. Kumar, A.B. Kunnumakkara, Possible use of Punica granatum (Pomegranate) in cancer therapy. Pharmacol. Res. 133, 53–64 (2018)
X. Cheng, X. Yao, S. Xu, J. Pan, H. Yu, J. Bao, H. Guan, R. Lu, L. Zhang, Punicalagin induces senescent growth arrest in human papillary thyroid carcinoma BCPAP cells via NF-kB signaling pathway. Biomed. Pharmacother. 103, 490–498 (2018)
X. Cheng, Y. Gao, X. Yao, H. Yu, J. Bao, H. Guan, Y. Sun, L. Zhang, Punicalagin induces apoptosis-independent autophagic cell death in human papillary thyroid carcinoma BCPAP cells. RSC Adv. 6(72), 68485–68493 (2016)
X. Yao, X. Cheng, L. Zhang, H. Yu, J. Bao, H. Guan, R. Lu, Punicalagin from pomegranate promotes human papillary thyroid carcinoma BCPAP cell death by triggering ATM-mediated DNA damage response. Nutr. Res. 47, 63–71 (2017)
Y. Li, T. Ye, F. Yang, M. Hu, L. Liang, H. He, Z. Li, A. Zeng, Y. Li, Y. Yao, Y. Xie, Z. An, S. Li, Punica granatum (pomegranate) peel extract exerts potent antitumor and anti-metastasis activity in thyroid cancer. RSC Adv. 6(87), 84523–84535 (2016)
S.M. Tang, X.T. Deng, J. Zhou, Q.P. Li, X.X. Ge, L. Miao, Pharmacological basis and new insights of quercetin action in respect to its anti-cancer effects. Biomed. Pharmacother. 121, 109604 (2020)
E. Mutlu Altundağ, T. Kasac, A.M. Yılmaz, B. Karademir, S. Koçtürk, Y. Taga, A.S. Yalçın, Quercetin-induced cell death in human papillary thyroid cancer (B-CPAP) cells. J. Thyroid Res. 2016, 9843675 (2016)
C.S. Yang, H. Wang, Cancer preventive activities of tea catechins. Molecules 21(12), 1679 (2016)
A. Negri, V. Naponelli, F. Rizzi, S. Bettuzzi, Molecular targets of epigallocatechin-gallate (EGCG): a special focus on signal transduction and cancer. Nutrients 10(12), 1936 (2018)
T. Li, N. Zhao, J. Lu, Q. Zhu, X. Liu, F. Hao, X. Jiao, Epigallocatechin gallate (EGCG) suppresses epithelial-Mesenchymal transition (EMT) and invasion in anaplastic thyroid carcinoma cells through blocking of TGF-β1/Smad signaling pathways. Bioengineered 10(1), 282–291 (2019)
D. Wu, Z. Liu, J. Li, Q. Zhang, P. Zhong, T. Teng, M. Chen, Z. Xie, A. Ji, Y. Li, Epigallocatechin-3-gallate inhibits the growth and increases the apoptosis of human thyroid carcinoma cells through suppression of EGFR/RAS/RAF/MEK/ ERK signaling pathway. Cancer Cell Int. 19, 43 (2019)
Y. Gao, S.A. Snyder, J.N. Smith, Y.C. Chen, Anticancer properties of baicalein: a review. Med. Chem. Res. 25(8), 1515–1523 (2016)
M. Wang, S. Qiu, J. Qin, Baicalein induced apoptosis and autophagy of undifferentiated thyroid cancer cells by the ERK/PI3K/Akt pathway. Am. J. Transl. Res. 11(6), 3341–3352 (2019)
L. Zhang, X. Cheng, Y. Gao, J. Zheng, Q. Xu, Y. Sun, H. Guan, H. Yu, Z. Sun, Apigenin induces autophagic cell death in human papillary thyroid carcinoma BCPAP cells. Food Funct. 6(11), 3464–3472 (2015)
F. Visioli, E. Bernardini, Extra virgin olive oil’s polyphenols: biological activities. Curr. Pharm. Des. 17, 786–804 (2011)
S. Bulotta, M. Oliverio, D. Russo, A. Procopio, Chapter 156: Biological activity of oleuropein and its derivatives. in Natural Products, eds. by K.G. Ramawat, J.M. Merillon (Springer-Verlag Berlin Heidelberg (2013), p. 3605–3638
M. Celano, V. Maggisano, S.M. Lepore, D. Russo, S. Bulotta, Secoiridoids of olive and derivatives as potential coadjuvant drugs in cancer: a critical analysis of experimental studies. Pharmacol. Res. 142, 77–86 (2019)
S. Bulotta, R. Corradino, M. Celano, J. Maiuolo, M. D’Agostino, M. Oliverio, A. Procopio, S. Filetti, D. Russo, Antioxidant and antigrowth action of peracetylated oleuropein in thyroid cancer cells. J. Mol. Endocrinol. 51(1), 181–189 (2013)
G. Toteda, S. Lupinacci, D. Vizza, R. Bonofiglio, E. Perri, M. Bonofiglio, D. Lofaro, A. La Russa, F. Leone, P. Gigliotti, R.A. Cifarelli, A. Perri, High doses of hydroxytyrosol induce apoptosis in papillary and follicular thyroid cancer cell. J. Endocrinol. Invest. 40(2), 153–162 (2017)
W. Liang, Y. Lai, M. Zhu, S. Huang, W. Feng, X. Gu, Combretastatin A4 regulates proliferation, migration, invasion, and apoptosis of thyroid cancer cells via PI3K/Akt signaling pathway. Med. Sci. Monit. 22, 4911–4917 (2016)
S.J. Hosseinimehr, S.A. Hosseini, Radiosensitive effect of curcumin on thyroid cancer cell death induced by radioiodine-131. Interdiscip. Toxicol. 7, 85–88 (2014)
S. Schwertheim, F. Wein, K. Lennartz, K. Worm, K.W. Schmid, S.Y. Sheu-Grabellus, Curcumin induces G2/M arrest, apoptosis, NF-kappaB inhibition, and expression of differentiation genes in thyroid carcinoma cells. J. Cancer Res. Clin. Oncol. 143, 1143–1154 (2017)
H.J. Kang, Y.K. Youn, M.K. Hong, L.S. Kim, Antiproliferation and redifferentiation in thyroid cancer cell lines by polyphenol phytochemicals. J. Korean Med. Sci. 26, 893–899 (2011)
A. Lakshmanan, D. Scarberry, J. Green, X. Zhang, S. Selmi-Ruby, S.M. Jhiang, Modulation of thyroidal radioiodide uptake by oncological pipeline inhibitors and Apigenin. Oncotarget 6, 31792–31804 (2015)
J.M.P. Ferreira de Oliveira, C. Santos, E. Fernandes, Therapeutic potential of hesperidin and its aglycone hesperetin: cell cycle regulation and apoptosis induction in cancer models. Phytomedicine 73, 152887 (2020)
P.N. Patel, X.M. Yu, R. Jaskula-Sztul, H. Chen, Hesperetin activates the Notch1 signaling cascade, causes apoptosis, and induces cellular differentiation in anaplastic thyroid cancer. Ann. Surg. Oncol. 21(4), 497–504 (2014)
L.S. Chua, A review on plant-based rutin extraction methods and its pharmacological activities. Ethnopharmacol 150(3), 805–817 (2013)
C.F.L. Gonçalves, M.C. Santos, M.G. Ginabreda, R.S. Fortunato, D.P. Carvalho, A.C.Freitas Ferreira, Flavonoid rutin increases thyroid iodide uptake in rats. PLoS ONE 8(9), e73908 (2013).
C.F.L. Goncalves, M.L. De Freitas, R.S. Fortunato, L.M. Alves, D.P. Carvalho, A.C. Freitas Ferrera, Rutin scavenges reactive oxygen species, inactivates 5’-adenosine monophosphate-activated protein kinase, and increases sodium-iodide symporter expression in thyroid PCCL3 cells. Thyroid 28(2), 265–275 (2018)
P. Bian, W. Hu, C. Liu, L. Li, Resveratrol potentiates the anti-tumor effects of rapamycin in papillary thyroid cancer: PI3K/AKT/mTOR pathway involved. Arch. Biochem. Biophys. 689, 108461 (2020)
J.M. Hong, C.S. Park, I.S. Nam-Goong, Y.S. Kim, J.C. Lee, M.W. Han, J.I. Choi, Y.I. Kim, E.S. Kim, Curcumin enhances docetaxel-induced apoptosis of 8505c anaplastic thyroid carcinoma cells. Endocrinol. Metab. 29, 54–61 (2014)
J. Zhang, J. Yu, R. Xie, W. Chen, Y. Lv, Combinatorial anticancer effects of curcumin and sorafenib towards thyroid cancer cells via pi3k/akt and erk pathways. Nat. Prod. Res. 30, 1858–1861 (2016)
C.H. Park, S.E. Han, I.S. Nam-Goong, Y.I. Kim, E.S. Kim, Combined effects of baicalein and docetaxel on apoptosis in 8505c anaplastic thyroid cancer cells via downregulation of the ERK and Akt/mTOR pathways. Endocrinol. Metab. 33, 121–132 (2018)
M. Celano, V. Maggisano, S. Bulotta, L. Allegri, V. Pecce, L. Abballe, G. Damante, D. Russo, Quercetin improves the effects of sorafenib on growth and migration of thyroid cancer cells. Endocrine 67, 496–498 (2020)
C.J. Mooney, G. Nagaiah, P. Fu, J.K. Wasman, M.M. Cooney, P.S. Savvides, J.A. Bokar, A. Dowlati, D. Wang, S.S. Agarwala, S.M. Flick, P.H. Hartman, J.D. Ortiz, P.N. Lavertu, S.C. Remick, A phase II trial of fosbretabulin in advanced anaplastic thyroid carcinoma and correlation of baseline serum-soluble intracellular adhesion molecule-1 with outcome. Thyroid 19(3), 233–240 (2009)
J.A. Sosa, R. Elisei, B. Jarzab, J. Balkissoon, S.P. Lu, C. Bal, S. Marur, A. Gramza, R.B. Yosef, B. Gitlitz, B.R. Haugen, F. Ondrey, C. Lu, S.M. Karandikar, F. Khuri, L. Licitra, S.C. Remick, Randomized safety and efficacy study of fosbretabulin with paclitaxel/carboplatin against anaplastic thyroid carcinoma. Thyroid 24(2), 232–240 (2014)
R. Granata, L.D. Locati, L. Licitra, Fosbretabulin for the treatment of anaplastic thyroid cancer. Future Oncol. 10(13), 2015–2021 (2014)
M. Sponziello, C. Brunelli, A. Verrienti, G. Grani, V. Pecce, L. Abballe, V. Ramundo, G. Damante, D. Russo, C.P. Lombardi, C. Durante, E.D. Rossi, P. Straccia, S. Filetti, Performance of a dual-component molecular assay in cytologically indeterminate thyroid nodules. Endocrine 68, 468–475 (2020)
F. Rosignolo, M. Sponziello, D. Russo, V. Pecce, L. Giacomelli, M. Biffoni, R. Bellantone, C.P. Lombardi, L. Lamartina, G. Grani, C. Durante, S. Filetti, A. Verrienti, Identification of thyroid-associated serum microRNA profiles and their potential use in thyroid cancer follow-up. J. Endocr. Soc. 1, 3–13 (2017)
M. Celano, F. Rosignolo, V. Maggisano, V. Pecce, M. Iannone, D. Russo, S. Bulotta, MicroRNAs as biomarkers in thyroid carcinoma. Int. J. Genomics 2017, 6496570 (2017)
F. Rosignolo, L. Memeo, F. Monzani, C. Colarossi, V. Pecce, A. Verrienti, C. Durante, G. Grani, L. Lamartina, S. Forte, D. Martinetti, D. Giuffrida, D. Russo, F. Basolo, S. Filetti, M. Sponziello, MicroRNA-based molecular classification of papillary thyroid carcinoma. Int. J. Oncol. 50(5), 1767–1777 (2017)
We wish to thank Melissa Kerr for the language revision of the paper.
Conflict of interest
The authors declare no competing interests.
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Bulotta, S., Capriglione, F., Celano, M. et al. Phytochemicals in thyroid cancer: analysis of the preclinical studies. Endocrine (2021). https://doi.org/10.1007/s12020-021-02651-y
- Thyroid cancer
- Combinatory treatment
- Preclinical studies